Main menu

NCM 2022: Identification of Leishmania infantum epidemiological, drug resistance and pathogenicity biomarkers


  • Leishmania infantum is a protist parasite and causative agent of leishmaniasis, endemic to many countries world-wide, per example the Mediterranean basin.
  • Emerging drug-resistant L. infantum is one of the most relevant neglected tropical disease, as it is responsible for 12M infections w/w and more than 25,000 deaths.
  • It possesses a genome of 32 Mb distributed in 36 chromosomes and a complex network of maxi- and minicircle kinetoplasts (functionally similar to mitochondria).
  • Its genome is structurally complex, with frequent rearrangements and aneuploidies. Such changes in copy number variation (CNV) occur as a result of environment adaptation and can be potentially used as genetic biomarkers to create a genetic resistance profile.

Download the PDF

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

纳米孔技术

订阅 Nanopore 更新 资源库及发表刊物 什么是 Nanopore 社区

关于 Oxford Nanopore

新闻 公司历程 可持续发展 领导团队 媒体资源和联系方式 投资者 合作者 在 Oxford Nanopore 工作 职位空缺 商业信息 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag